1Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet; in press.
Web of Science® Google Scholar
2Kardaun SH, Sidoroff A, Valeyrie-Allanore L et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156: 609–11.
10.1111/j.1365-2133.2006.07704.x
CAS PubMed Web of Science® Google Scholar
3Pinto Gouveia M, Gameiro A, Coutinho I et al. Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward. Br J Dermatol 2016; 175: 1274–83.
10.1111/bjd.14704
CAS PubMed Web of Science® Google Scholar
4Ortonne N, Valeyrie-Allanore L, Bastuji-Garin S et al. Histopathology of drug rash with eosinophilia and systemic symptom syndrome: a morphological and phenotypical study. Br J Dermatol 2015; 173: 50–8.
10.1111/bjd.13683
CAS PubMed Web of Science® Google Scholar
5Bouvresse S, Valeyrie-Allanore L, Ortonne N et al. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist? Orphanet J Rare Dis 2012; 7: 72.
10.1186/1750-1172-7-72
PubMed Web of Science® Google Scholar
6Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions – new concepts. Clin Exp Allergy 2007; 37: 989–99.
10.1111/j.1365-2222.2007.02742.x
CAS PubMed Web of Science® Google Scholar
7Chessman D, Kostenko L, Lethborg T et al. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 2008; 28: 822–32.
10.1016/j.immuni.2008.04.020
CAS PubMed Web of Science® Google Scholar
8Chen P, Lin JJ, Lu CS et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 2011; 364: 1126–33.
10.1056/NEJMoa1009717
CAS PubMed Web of Science® Google Scholar
9Takahashi R, Kano Y, Yamazaki Y et al. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009; 182: 8071–9.
10.4049/jimmunol.0804002
CAS PubMed Web of Science® Google Scholar
10Chung WH, Hung SI, Yang JY et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008; 14: 1343–50.
10.1038/nm.1884
CAS PubMed Web of Science® Google Scholar
11Saito N, Qiao H, Yanagi T et al. An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions. Sci Transl Med 2014; 6: 245ra95.
10.1126/scitranslmed.3008227
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume175, Issue6

December 2016

Pages 1142-1144

Is DRESS syndrome a single entity or within a spectrum of adverse reactions to drug?

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Is DRESS syndrome a single entity or within a spectrum of adverse reactions to drug?

Abstract

References

Citing Literature

References

Related

Information